{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-054845","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2025-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.588521+00:00","generated_at":"2026-05-24T18:07:27.841611+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enovis CEO Trerotola signs retirement transition; will serve as Special Advisor for 1 year post-successor","bullets":["CEO Matthew Trerotola's retirement effective when successor appointed; transition agreement signed March 13, 2025.","He will serve as Special Advisor for one year after Appointment Date, receiving current $1,077,000 base salary for two months then reduced (min 50%).","No further equity or long-term incentive awards; outstanding awards continue per retirement provisions in equity agreements.","Non-compete applies for two years after Retirement Date in orthopedic and medical device business; non-solicitation and non-disparagement also in place.","Successor CEO has not yet been named by the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-054845","json":"https://secwatch.observer/filing/0001193125-25-054845.json","markdown":"https://secwatch.observer/filing/0001193125-25-054845.md","text":"https://secwatch.observer/filing/0001193125-25-054845.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000119312525054845/0001193125-25-054845-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000119312525054845/d786749d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T18:07:27.841611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43d4ae007d","claim":"Matthew L. Trerotola changed role as Chief Executive Officer at Enovis CORP.","evidence_excerpt":"As previously announced by Enovis Corporation (the “Company”), on February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of the Company of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company (the “Appointment Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420800/000119312525054845/0001193125-25-054845-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}